American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

Cited by (498)

Items 101–200 of 498

  1. Telehealth—An Effective Delivery Method for Diabetes Self-Management Education?
    Fitzner, Karen, Moss, Gail · 2013 · Population Health Management
  2. Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?
    Wonjin Kim, Soo Kyung Park, Yoo Lee Kim · 2019 · PLoS ONE
  3. Transcultural Diabetes Nutrition Algorithm (tDNA): Venezuelan Application
    Ramfis E Nieto-Martínez, Osama Hamdy, Daniel Marante, María Inés Marulanda, Albert E. Marchetti, Refaat A. F. Hegazi, Jeffrey Ian Mechanick · 2014 · Nutrients
  4. Sodium–glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus
    Philip Raskin · 2013 · Diabetes/Metabolism Research and Reviews
  5. Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD.
    A. Dokun, Lingdan Chen, Swapnil S. Lanjewar, R. Lye, B. Annex · 2014 · Cardiovascular Research
  6. Insulin Therapy in Type 2 Diabetes Mellitus: A Practical Approach for Primary Care Physicians and Other Health Care Professionals
    J. Lasalle, R. Berria · 2013 · The Journal of the American Osteopathic Association
  7. Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice.
    Wen-Long Sun, Bo-Wei Zhang, Xiao-Xia Yu, Chun-Lin Zhuang, Xia Li, Jin Sun, Y.-Q. Xing, Z. Xiu, Yue-Sheng Dong · 2018 · Phytomedicine
  8. Patient empowerment and optimal glycemic control
    White, Russell D. · 2012 · Current Medical Research and Opinion
  9. A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
    Zhang, Yurong, Hu, Gang, Zhang, Lu, Mayo, Rachel, Chen, Liwei · 2015 · PLOS ONE
  10. Temporal trends of hemoglobin A1c testing
    Pivovarov, Rimma, Albers, David J, Hripcsak, George, Sepulveda, Jorge L, Elhadad, Noémie · 2014 · Journal of the American Medical Informatics Association
  11. Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
    Michelle C. Kaku, Aaron I. Vinik, David M. Simpson · 2015 · Current Diabetes Reports
  12. Impact of chronic disease self-management programs on type 2 diabetes management in primary care
    Samuel Nana Forjuoh · 2014 · World Journal of Diabetes
  13. Cardiorenal Metabolic Syndrome and Cardiometabolic Risks in Minority Populations
    Keith C. Ferdinand, Fátima Rodríguez, Samar A. Nasser, Augusto Enrique Caballero, Gary A. Puckrein, Farhad Zangeneh, Michael Mansour, JoAnne Micale Foody, Priscilla E. Pemu, Elizabeth Ofili · 2013 · Cardiorenal Medicine
  14. Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial
    Stuart A. Ross, Elizabeth Rafeiro, Thomas W. Meinicke, Robert Toorawa, Sonja Weber-Born, Hans‐Juergen Woerle · 2012 · Current Medical Research and Opinion
  15. Liraglutide: from clinical trials to clinical practice
    Stephen C. L. Gough · 2012 · Diabetes Obesity and Metabolism
  16. Benefits and Risks for Intensive Glycemic Control in Patients With Diabetes Mellitus
    Lawrence Blonde · 2011 · The American Journal of the Medical Sciences
  17. Glycemic Variability in Type 2 Diabetes Mellitus
    Eric L. Johnson · 2012 · Advances in experimental medicine and biology
  18. Hypoglycemia: Minimizing its impact in type 2 diabetes
    Moghissi, Etie, Ismail-Beigi, Faramarz, Devine, Robin Cammarota · 2013 · Endocrine Practice
  19. Accuracy and Clinical Utility of a Point-of-Care HbA1c, Testing Device
    Jennifer Knaebel, B. Irvin, Charles Z Xie · 2013 · Postgraduate medicine
  20. Evaluating Second-Line Treatment Options for Type 2 Diabetes: Focus on Secondary Effects of GLP-1 Agonists and DPP-4 Inhibitors
    Cassie L. Boland, Michelle DeGeeter, Donald S. Nuzum, Maria Tzefos · 2013 · Annals of Pharmacotherapy
  21. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
    Fraticelli, Federica, Celentano, Claudio, Zecca, Isaia AL, Di Vieste, Giacoma, Pintaudi, Basilio, Liberati, Marco, Franzago, Marica, Di Nicola, Marta, Vitacolonna, Ester · 2018 · Acta Diabetologica
  22. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia
    Mohammed Ali Batais, Peter Schantter · 2016 · Primary care diabetes
  23. Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study
    Pablo J. Aschner, Bipin Kumar Sethi, Fernando Gómez Peralta, Wolfgang Landgraf, Virginie Loizeau, Marie‐Paule Dain, Valérie Pilorget, Abdurrahman Çömlekçi · 2015 · Journal of Diabetes and its Complications
  24. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME‐DM) study
    Marsha A. Raebel, Jennifer L. Ellis, Emily B. Schroeder, Stanley Xu, Patrick J. O’Connor, Jodi B Segal, Melissa G. Butler, Julie A. Schmittdiel, Henry Lester Kirchner, Glenn K. Goodrich et al. · 2014 · Pharmacoepidemiology and Drug Safety
  25. Vitamin D and Prebiotics may benefit The Intestinal Microbacteria and improve Glucose Homeostasis in Prediabetes and Type 2 Diabetes
    Elena I. Barengolts · 2013 · Endocrine Practice
  26. Glucose‐lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register
    N. Ekström, M. Miftaraj, A. Svensson, K. Sundell, J. Cederholm, B. Zethelius, S. Gudbjornsdottir, B. Eliasson · 2012 · Diabetes, obesity and metabolism
  27. Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Martin J. Abrahamson, Anne L. Peters · 2012 · Annals of Medicine
  28. The meaning of insulin to Hispanic immigrants with type 2 diabetes and their families.
    Jie Hu, Karen A. Amirehsani, D. Wallace, S. Letvak · 2012 · The diabetes educator
  29. Reconsidering the age thresholds for type II diabetes screening in the U.S
    Chung, Sukyung, Azar, Kristen M.J., Baek, Marshall, Lauderdale, Diane S., Palaniappan, Latha P. · 2014 · American Journal of Preventive Medicine
  30. Behavioral and technological interventions targeting glycemic control in a racially/ethnically diverse population: a randomized controlled trial
    Forjuoh, Samuel N, Bolin, Jane N, Huber Jr, John C, Vuong, Ann M, Adepoju, Omolola E, Helduser, Janet W, Begaye, Dawn S, Robertson, Anne, Moudouni, Darcy M, Bonner, Timethia J et al. · 2014 · BMC Public Health
  31. Risk category system to identify pituitary adenoma patients with AIP mutations
    Francisca Caimari, Laura Cristina Hernández-Ramírez, Mary N. Dang, Plamena N. Gabrovska, Donato Iacovazzo, Karen Lucy Stals, Sian Ellard, Márta Korbonits · 2018 · Journal of Medical Genetics
  32. Diabetes management unawareness: what do bedside nurses know?
    Mary Beth Modic, Anne S. Vanderbilt, Sandra L. Siedlecki, Rebecca Sauvey, Nancy Kaser, Christina Yager · 2013 · Applied Nursing Research
  33. Prognostic value of malnutrition using geriatric nutritional risk index in patients with coronary chronic total occlusion after percutaneous coronary intervention.
    Lele Cheng, Jie Rong, Xiao-Zhen Zhuo, Ke Gao, Zixuan Meng, X. Wen, Shan-shan Li, Peng Fan, X. Hao, Z. Jian et al. · 2021 · Clinical Nutrition
  34. Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry
    S. Arnold, S. Inzucchi, D. McGuire, Sanjeev N. Mehta, A. Goyal, L. Sperling, T. Maddox, D. Einhorn, N. Wong, R. Ratner et al. · 2016 · Diabetes Care
  35. Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence
    Yue Zhong, Pei‐Jung Lin, Joshua T. Cohen, Aaron N. Winn, Peter J. Neumann · 2015 · Value in Health
  36. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients
    I. Aslan, E. Kucuksayan, M. Aslan · 2013 · Lipids in Health and Disease
  37. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study
    Lisha Zhang, C. Xu, Jun-Hui Liu, Xiaofang Bai, Rui-Feng Li, Li-Jun Wang, Juan Zhou, Yuehua Wu, Z. Yuan · 2019 · Cardiovascular Diabetology
  38. The expression of sirtuins, superoxide dismutase, and lipid peroxidation status in peripheral blood from patients with diabetes and hypothyroidism
    A.-H. Al-Khaldi, Samar Sultan · 2019 · BMC Endocrine Disorders
  39. A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
    A. King, Akio Kuroda, M. Matsuhisa, T. Hobbs · 2016 · Current Diabetes Reports
  40. Postprandial C ‐peptide to glucose ratio as a predictor of β‐cell function and its usefulness for staged management of type 2 diabetes
    Eun Young Lee, Sena Hwang, Seo Hee Lee, Yong‐ho Lee, A.R. Choi, Youngki Lee, Byung‐Wan Lee, Eun Seok Kang, Chul Woo Ahn, Bong Soo et al. · 2014 · Journal of Diabetes Investigation
  41. Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network
    C. Ferrajolo, P. Coloma, K. Verhamme, M. Schuemie, S. de Bie, R. Gini, R. Herings, G. Mazzaglia, G. Picelli, C. Giaquinto et al. · 2014 · Drug Safety
  42. Management of Polycystic Ovary Syndrome in India
    Sonia Malik, Kuldeep Jain, Pankaj Talwar, S. Prasad, Bharti Dhorepatil, G. Devi, Ashok Khurana, Vandana Bhatia, Nomita Chandiok, Alka Kriplani et al. · 2014 · Fertility Science and Research
  43. Coronary artery calcium scanning in asymptomatic patients with diabetes mellitus: A paradigm shift
    H. Hecht, J. Narula · 2012 · Journal of Diabetes
  44. Hemoglobin A1c is associated with severity of coronary artery stenosis but not with long term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty
    J. She, Yangyang Deng, Yuehua Wu, Yulong Xia, Hong-Bing Li, Xiao Liang, Rui Shi, Z. Yuan · 2017 · Cardiovascular Diabetology
  45. Limitations of A1c Interpretation
    J. Shepard, Anita Airee, Andrew W. Dake, M. McFarland, Amit Vora · 2015 · Southern medical journal (Birmingham, Ala. Print)
  46. Association Between Hyperglycemia at Admission During Hospitalization for Acute Myocardial Infarction and Subsequent Diabetes: Insights From the Veterans Administration Cardiac Care Follow-up Clinical Study
    Supriya Shore, Joleen A. Borgerding, Ina Gylys-Colwell, Kelly A. McDermott, P. Michael Ho, Maggie N. Tillquist, Elliott Lowy, Darren K. McGuire, Joshua M. Stolker, Suzanne V. Arnold et al. · 2013 · Diabetes Care
  47. Is insulin the most effective injectable antihyperglycaemic therapy?
    Buse, J. B., Peters, A., Russell‐Jones, D., Furber, S., Donsmark, M., Han, J., MacConell, L., Maggs, D., Diamant, M. · 2015 · Diabetes, Obesity and Metabolism
  48. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study
    Michel Paul Hermans, Tuncay Delibaşı, Ian Farmer, Leif Lohm, Pierre Maheux, PierMarco Piatti, Elmas Malvolti, Silke Jörgens, Bernard H. Charbonnel · 2012 · Current Medical Research and Opinion
  49. Preoperative geriatric assessment: Comprehensive, multidisciplinary and proactive
    Sheilesh Kumar Dewan, Song Zheng, Shi Jin Xia · 2012 · European Journal of Internal Medicine
  50. Pharmaceutical care-based interventions in type 2 diabetes mellitus : a systematic review and meta-analysis of randomized clinical trials
    Marcel Nogueira, Leonardo Jun Otuyama, Priscilla Alves Rocha, Vanusa Barbosa Pinto · 2020 · Einstein (São Paulo)
  51. Impact of clinical inertia on cardiovascular risk factors in patients with diabetes.
    D. Whitford, Hussam A Al-Anjawi, Marwa M Al-Baharna · 2014 · Primary Care Diabetes
  52. Utility of the U.S. Preventive Services Task Force Criteria for Diabetes Screening
    Sarah Stark Casagrande, Catherine C. Cowie, JUDITH E. FRADKIN · 2013 · American Journal of Preventive Medicine
  53. Review of Insulin-Dependent and Insulin-Independent Agents for Treating Patients With Type 2 Diabetes Mellitus and Potential Role for Sodium-Glucose Co-Transporter 2 Inhibitors
    Jeffrey S. Freeman · 2013 · Postgraduate Medicine
  54. Value and Utility of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Patients With Type 2 Diabetes Mellitus
    Thomas Blevins · 2013 · Postgraduate Medicine
  55. Identifying and Addressing Barriers to Insulin Acceptance and Adherence in Patients With Type 2 Diabetes Mellitus
    Allison M Petznick · 2013 · The Journal of the American Osteopathic Association
  56. Saxagliptin
    Lily P H Yang · 2012 · Drugs
  57. A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
    Eduard Montanya · 2012 · Expert Opinion on Pharmacotherapy
  58. Rationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetes
    Lawrence Blonde, John E. Anderson, Pavan Chava, Jared A. Dendy · 2018 · Current Medical Research and Opinion
  59. Race and Referral to Diabetes Education in Primary Care Patients With Prediabetes and Diabetes
    Denise R. Hooks-Anderson, Erica F. Crannage, Joanne Salas, Jeffrey F. Scherrer · 2015 · The Science of Diabetes Self-Management and Care
  60. Treat-to-target trials in diabetes
    SubhashK Wangnoo, Bipin Kumar Sethi, Rakesh Kumar Sahay, Mathew John, Samit Ghosal, SurendraK Sharma · 2014 · Indian Journal of Endocrinology and Metabolism
  61. Influence of Chronic Hyperglycemia on Cerebral Microvascular Remodeling: An In Vivo Study Using Perfusion Computed Tomography in Acute Ischemic Stroke Patients
    Qing-Hua Hou, Z. Zuo, P. Michel, Yan-Rong Zhang, A. Eskandari, F. Man, Q. Gao, K. Johnston, M. Wintermark · 2013 · Stroke
  62. Public Health Implications of Recommendations to Individualize Glycemic Targets in Adults With Diabetes
    Neda Laiteerapong, Priya M. John, Aviva G. Nathan, Elbert S. Huang · 2012 · Diabetes Care
  63. Type 2 Diabetes Mellitus: Practical Approaches for Primary Care Physicians
    J. R. Gavin, J. Freeman, J. Shubrook, F. Lavernia · 2011 · The Journal of the American Osteopathic Association
  64. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Z. Velija-Ašimi, Azra Bureković, T. Dujić, Amela Dizdarević-Bostandžić, S. Semiz · 2016 · Bosnian Journal of Basic Medical Sciences
  65. Unleash Metformin
    Wenya R. Lu, Jennifer L. Defilippi, Amy Braun · 2013 · Annals of Pharmacotherapy
  66. The need for better insulin therapy
    G. Grunberger · 2013 · Diabetes, obesity and metabolism
  67. The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management
    V. Valentine · 2012 · Clinical Diabetes
  68. The Role of Incretin Therapy at Different Stages of Diabetes
    Simona Cernea · 2011 · The Review of Diabetic Studies
  69. Adolescent bariatric surgery: a systematic review of recommendation documents
    Janet E. Childerhose, Amal Alsamawi, Tanvi Mehta, Judith Smith, Susan J. Woolford, Beth Anne Tarini · 2017 · Surgery for Obesity and Related Diseases
  70. A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes
    Stefano Genovese, Edoardo Mannucci, Antonio Ceriello · 2017 · Advances in Therapy
  71. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
    Wei-Sin Li, Chen-Hsiang Lee, Jien-Wei Liu · 2017 · Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
  72. A new predictive tool for the early risk assessment of gestational diabetes mellitus.
    C. Capula, E. Chiefari, M. Borelli, Rosa Oliverio, Anna Vero, D. Foti, L. Puccio, R. Vero, A. Brunetti · 2016 · Primary Care Diabetes
  73. Acromegaly: Assessing the Disorder and Navigating the Therapeutic Options for Treatment
    Shlomo K. Melmed, David L. Kleinberg, Vivien S. Bonert, Maria Fleseriu · 2014 · Endocrine Practice
  74. Health Care Provider Management of Patients With Type 2 Diabetes Mellitus: Analysis of Trends in Attitudes and Practices
    Chad R. Williamson, Terry Ann Glauser, B. Stephen Burton, Doron Schneider, Anne Marie Dubois, Daxa Patel · 2014 · Postgraduate Medicine
  75. A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    J. White, P. Buchanan, Jia Li, R. Frederich · 2014 · BMC Endocrine Disorders
  76. Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes
    Stefano Genovese, Giorgia De Berardis, Antonio Nicolucci, Edoardo Mannucci, Virgilio Evangelista, Licia Totani, Fabio Pellegrini, Antonio Ceriello · 2013 · Advances in Therapy
  77. Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
    Oliseyenum M. Nwose, Michael R. Jones · 2013 · Clinical Medicine Insights Endocrinology and Diabetes
  78. Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease
    Robert Klempfner, Jonathan Leor, Alexander Tenenbaum, Enrique Z. Fisman, Ilan Goldenberg · 2012 · Cardiovascular Diabetology
  79. Development and Validation of a Computer Application to Aid the Physician's Decision-Making Process at the Start of and during Treatment with Insulin in Type 2 Diabetes: A Randomized and Controlled Trial
    A. Sáenz, Miguel Brito, I. Morón, A. Torralba, E. García-Sanz, J. Redondo · 2012 · Journal of Diabetes Science and Technology
  80. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects
    A. Berbudi, N. Rahmadika, Adi Tjahjadi, R. Ruslami · 2020 · Journal of Diabetes Research
  81. Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
    Inka Miñambres, Javier Mediavilla, Jordi Sarroca, Antonio Pérez · 2016 · BMC Endocrine Disorders
  82. Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Single- and multiple-dose Once-daily Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Chinese Patients With Type 2 Diabetes Mellitus.
    Xia Zhao, Yi-Min Cui, Shuai Zhao, B. Lang, Uli C. Broedl, Afshin Salsali, Sabine Pinnetti, S. Macha · 2015 · Clinical Therapeutics
  83. Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
    Robert Alan Vigersky · 2015 · Journal of Diabetes Science and Technology
  84. Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
    Philip Raskin, Katherine Mann · 2014 · Diabetes Metabolic Syndrome and Obesity
  85. HbA1c levels in patients with gestational diabetes mellitus: Relationship with pre-pregnancy BMI and pregnancy outcome.
    Carmelo Capula, Tommaso Mazza, Raffaella Vero, Giuseppe Costante · 2013 · PubMed
  86. Using Multiple Measures of Glycemia to Support Individualized Diabetes Management: Recommendations for Clinicians, Patients, and Payers
    Irl B. Hirsch, Stephanie A. Amiel, Ian R. Blumer, Bruce W. Bode, Steven V. Edelman, Jane Jeffrie Seley, Carol A. Verderese, Eric S. Kilpatrick · 2012 · Diabetes Technology & Therapeutics
  87. Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus.
    Emmanuel N Chapp-Jumbo, Chimaroke Edeoga, J. Wan, S. Dagogo-Jack · 2012 · Endocrine Practice
  88. Pharmacists’ Impact on Improving Outcomes in Patients With Type 2 Diabetes Mellitus
    Matthew J. Pepper, N. Mallory, T. Coker, Amber L. Chaki, K. Sando · 2012 · The diabetes educator
  89. Managing Diabetes with Integrated Teams: Maximizing Your Efforts with Limited Time
    D. Kruger, Gayle M. Lorenzi, B. Dokken, Christopher E. Sadler, Kelly Mann, V. Valentine · 2012 · Postgraduate medicine
  90. The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
    Lele Cheng, Zixuan Meng, Qi Wang, Z. Jian, Pengcheng Fan, Xinxin Feng, Xiangrui Qiao, Jian Yang, Z. Yuan, Bolin Li et al. · 2021 · Frontiers in Cardiovascular Medicine
  91. Development and Implementation of a Subcutaneous Insulin Clinical Decision Support Tool for Hospitalized Patients
    Nestoras Nicolas Mathioudakis, Rebecca Jeun, Gerald Godwin, Annette Perschke, Swaytha Yalamanchi, Estelle Marla Everett, Peter S. Greene, Amy M. Knight, Christina T. Yuan, Sherita Hill Golden · 2018 · Journal of Diabetes Science and Technology
  92. Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry ®
    Suzanne V. Arnold, Abhinav Goyal, Silvio E. Inzucchi, Darren K. McGuire, Fengming Tang, Sanjeev N. Mehta, Laurence S. Sperling, Thomas M. Maddox, DANIEL F. EINHORN, Nathan D. Wong et al. · 2017 · Journal of the American Heart Association
  93. Aspirin for primary prevention of cardiovascular disease in patients with diabetes: A meta-analysis
    Lianne Kokoska, Sheila M. Wilhelm, Candice L. Garwood, Helen D Berlie · 2016 · Diabetes Research and Clinical Practice
  94. Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: A narrative review
    S. Elizarova, G. Galstyan, B. Wolffenbuttel · 2014 · Journal of Diabetes
  95. Controversies in Prediabetes: Do We Have a Diagnosis?
    Priscilla A. Hollander, Craig Spellman · 2012 · Postgraduate Medicine
  96. Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%.
    A. King, E. Montanya, R. Pratley, L. Blonde, C. B. Svendsen, M. Donsmark, G. Sesti · 2013 · Endocrine Practice
  97. Second line therapy: type 2 diabetic subjects failing on metformin GLP‐1/DPP‐IV inhibitors versus sulphonylurea/insulin: For GLP‐1/DPP‐IV inhibitors
    Ajay Kumar · 2012 · Diabetes/Metabolism Research and Reviews
  98. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    H. Bays · 2011 · Endocrine Practice
  99. Dapagliflozin, metformin, monotherapy or both in patients with metabolic syndrome
    Lap Cheng, Qian-Yu Fu, Longhua Zhou, Yuan Fan, Fen-Fen Liu, Yuan-Yuan Fan, X. Zhang, Wei-Zhan Lin, Xiaohe Wu · 2021 · Scientific Reports
  100. Importance of Hemoglobin A1c Levels for the Detection of Post-Surgical Infection Following Single-Level Lumbar Posterior Fusion in Patients with Diabetes
    J. Hwang, D. Son, K. T. Kang, Su-Hun Lee, J. Lee, G. Song, Sang Weon Lee, S. Sung · 2019 · Korean Journal of Neurotrauma